Long-term data support first-line use of avelumab and axitinib for advanced kidney cancer
A recent paper published in The Oncologist has shown that [...]
A recent paper published in The Oncologist has shown that [...]
At the 2023 Society of Urologic Oncology (SUO) Annual Meeting, [...]
A biomarker is a biological molecule found in blood, other body [...]
Results from the NeoAvAx clinical trial were presented at the [...]
The Sottish Medicine Consortium (SMC) have issued a final decision to recommend [...]
To date, a reliable biomarker is yet to be discovered [...]
KCSN are formal consultants to NICE and part of the [...]
In this video interview from Practice Update, Dr Eric Jonasch [...]
Two small studies reported on patients whose kidney cancer had [...]
Approval of axitinib plus pembrolizumab and axitinib plus avelumab in [...]